Psoriasis Completed Phase 2 Trials for Abatacept (DB01281)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01999868Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis VulgarisTreatment